We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPK:INDEXSpike Index Analysis

Data as of 2026-03-15 - not real-time

$6.49

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Spark New Zealand trades around $6.49, roughly 9% below its DCF fair value of $7.08, indicating a modest upside. The stock carries an eye‑catching dividend yield of 10.4% but a payout ratio near 200%, raising concerns about sustainability. Fundamentals show a solid free cash flow generation of $361.8 M and a trailing P/E of 15.5, which is below the industry average of 17.8, suggesting relative value appeal. However, the balance sheet is heavily leveraged with a debt‑to‑equity of 171, and the high dividend payout may be at risk if cash generation falters.
Technical indicators are bearish: the 20‑day SMA (6.62) sits just above the current price, the MACD histogram is negative and the signal line is bearish, while RSI at 41 points to limited upside momentum. Volume is on a decreasing trend, support sits at $6.23 and resistance at $6.79, and the 30‑day volatility of 18% combined with a beta of 0.07 underscores low market‑wide risk but heightened price swing potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume signal limited near‑term upside
  • Current price near support level reduces upside potential
  • High dividend payout ratio may lead to dividend cuts

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF suggests ~9% upside and price is below fair value
  • Strong free cash flow supports earnings stability
  • P/E below industry average indicates relative value

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable telecom market with consistent cash generation
  • Elevated debt levels and unsustainable dividend payout pose headwinds
  • Low beta and regulated environment limit systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth-1.20%
Profit Margin7.81%
P/E Ratio15.5
ROE19.72%
ROA6.65%
Debt/Equity171.20
P/B Ratio15.7
Op. Cash Flow$1.0B
Free Cash Flow$361.8M
Industry P/E17.8

Technical Analysis

TrendBearish
RSI41.1
Support$6.23
Resistance$6.79
MA 20$6.62
MA 50$6.63
MA 200$6.89
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$7.08
Target Price$7.10
Upside/Downside9.40%
GradeUndervalued
TypeValue
Dividend Yield10.40%

Risk Assessment

Beta0.10
Volatility18.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.